Scorpius Holdings Inc (SCPX)
0.0242
0.00 (0.00%)
USD |
NYAM |
Jun 26, 16:00
Scorpius Holdings Revenue (Annual): 6.995M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.995M |
| December 31, 2022 | 0.3702M |
| December 31, 2021 | |
| December 31, 2020 | 2.948M |
| December 31, 2019 | 3.049M |
| December 31, 2018 | 5.794M |
| December 31, 2017 | 1.520M |
| Date | Value |
|---|---|
| December 31, 2016 | 0.3416M |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | 0.0031M |
| December 31, 2011 | 0.1878M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.3702M
Minimum
2022
6.995M
Maximum
2023
3.340M
Average
2.998M
Median
Revenue (Annual) Benchmarks
| Biolase Inc | 49.16M |
| GT Biopharma Inc | -- |
| Akoya Biosciences Inc | 96.63M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.854M |